Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide

Journal of Colloid and Interface Science

Volumn 467, Issue , 2016, Pages 35-42

  Zheng, Xin Ting ^b   Ma, Xiao Qing ^b   Li, Chang Ming ^a,b  

^a SUZHOU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SOUTHWEST UNIVERSITY   (China)

Author keywords

Anti cancer drugs; Breast cancer; Drug delivery; Endocytosis; Poly l lysine; Reduced graphene oxide

Indexed keywords

AMINO ACIDS; ANTIBODIES; CELLS; CYTOLOGY; DISEASES; DRUG DELIVERY; MOLECULAR BIOLOGY;

ANTICANCER DRUG; BREAST CANCER; ENDOCYTOSIS; POLY-L-LYSINE; REDUCED GRAPHENE OXIDES;

GRAPHENE;

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GRAPHENE OXIDE; NANOCARRIER; NANOSHEET; POLYLYSINE; ANTINEOPLASTIC AGENT; DRUG CARRIER; GRAPHITE; OXIDE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL NUCLEUS; COLLOID; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG PENETRATION; DRUG UPTAKE; ENERGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; PINOCYTOSIS; PRIORITY JOURNAL; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; MCF-7 CELL LINE; OXIDATION REDUCTION REACTION; PARTICLE SIZE; STRUCTURE ACTIVITY RELATION; SURFACE PROPERTY; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; GRAPHITE; HUMANS; MCF-7 CELLS; OXIDATION-REDUCTION; OXIDES; PARTICLE SIZE; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES; TUMOR CELLS, CULTURED;

EID: 84953304660     PISSN: 00219797     EISSN: 10957103     Source Type: Journal    
DOI: 10.1016/j.jcis.2015.12.052     Document Type: Article

References (37)

1. Shi D., Bedford N.M., Cho H.S. Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics. Small 2011, 7:2549-2567.
2. Wang Y., Li Z.H., Wang J., Li J.H., Lin Y.H. Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends Biotechnol. 2011, 29:205-212.
3. Liu Y., Dong X., Chen P. Biological and chemical sensors based on graphene materials. Chem. Soc. Rev. 2012, 41:2283-2307.
4. Zheng X.T., Li C.M. Single cell analysis at the nanoscale. Chem. Soc. Rev. 2012, 41:2061-2071.
5. Suhas D.P., Raghu A.V., Jeong H.M., Aminabhavi T.M. Graphene-loaded sodium alginate nanocomposite membranes with enhanced isopropanol dehydration performance via a pervaporation technique. RSC Adv. 2013, 3:17120-17130.
6. Han S.J., Lee H.I., Jeong H.M., Kim B.K., Raghu A.V., Reddy K.R. Graphene modified lipophilically by stearic acid and its composite with low density polyethylene. J. Macromol. Sci., Part B 2014, 53:1193-1204.
7. Akhavan O., Ghaderi E. Graphene nanomesh promises extremely efficient in vivo photothermal therapy. Small 2013, 9:3593-3601.
8. Jiang Y., Wang B., Meng F., et al. Microwave-assisted preparation of N-doped carbon dots as a biosensor for electrochemical dopamine detection. J. Colloid Interface Sci. 2015, 452:199-202.
9. Wang C.J., Chen T.C., Lin J.H., et al. One-step preparation of hydrophilic carbon nanofiber containing magnetic Ni nanoparticles materials and their application in drug delivery. J. Colloid Interface Sci. 2015, 440:179-188.
10. Rao C., Sood A., Subrahmanyam K., Govindaraj A. Graphene: the new two-dimensional nanomaterial. Angew. Chem. Int. Ed. 2009, 48:7752-7777.
11. Liu Z., Robinson J.T., Sun X.M., Dai H.J. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 2008, 130:10876-10877.
12. Siriviriyanun A., Popova M., Imae T., et al. Preparation of graphene oxide/dendrimer hybrid carriers for delivery of doxorubicin. Chem. Eng. J. 2015, 281:771-781.
13. Zhang L.M., Xia J.G., Zhao Q.H., Liu L.W., Zhang Z.J. Graphene based gene transfection. Small 2010, 537-544.
14. Sun X.M., Liu Z., Welsher K., Robinson J.T., Goodwin A., Zaric S., et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 2008, 1:203-212.
15. Xu H., Fan M., Elhissi A.M.A., et al. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel. Nanomedicine 2015, 10:1247-1262.
16. Chen B.A., Liu M., Zhang L.M., Huang J., Yao J.L., Zhang Z.J. Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector. J. Mater. Chem. 2011, 21:7736-7741.
17. Liu K.P., Zhang J.J., Cheng F.F., Zheng T.T., Wang C.M., Zhu J.J. Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery. J. Mater. Chem. 2011, 21:12034-12040.
18. Bao H.Q., Pan Y.Z., Ping Y., Sahoo N.G., Wu T.F., Li L., et al. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 2011, 7:1569-1578.
19. Yang X.Y., Wang Y.S., Huang X., Ma Y.F., Huang Y., Yang R.C., et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J. Mater. Chem. 2011, 21:3448-3454.
20. Park Y.H., Park S.Y., In I. Direct noncovalent conjugation of folic acid on reduced graphene oxide as anticancer drug carrier. J. Ind. Eng. Chem. 2015, 30:190-196.
21. Rajendran L., Knolker H.J., Simons K. Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discovery 2010, 9:29-42.
22. Mao Z., Zhou X., Gao C. Influence of structure and properties of colloidal biomaterials on cellular uptake and cell functions. Biomater. Sci. 2013, 1:896-911.
23. Kavitha T., Kang I.K., Park S.Y. Poly (4-vinyl pyridine)-grafted graphene oxide for drug delivery and antimicrobial applications. Polym. Int. 2015, 64:1660-1666.
24. Zhou Z.X., Shen Y.Q., Tang J.B., Fan M.H., Van Kirk E.A., Murdoch W.J., et al. Charge-reversal drug conjugate for targeted cancer cell nuclear drug delivery. Adv. Funct. Mater. 2009, 19:3580-3589.
25. 4@C nanoparticles as drug carriers with high drug loading capability, pH-control drug release and MRI properties. Biomater. Sci. 2013, 1:965-974.
26. Ma X., Ong O.S., Zhao Y. Dual-responsive drug release from oligonucleotide-capped mesoporous silica nanoparticles. Biomater. Sci. 2013, 1:912-917.
27. Sethi K., Roy I. Organically modified titania nanoparticles for sustained drug release applications. J. Colloid Interface Sci. 2015, 456:59-65.
28. Shan C.S., Yang H.F., Han D.X., Zhang Q.X., Ivaska A., Niu L. Water-soluble graphene covalently functionalized by biocompatible poly-l-lysine. Langmuir 2009, 25:12030-12033.
29. Colombo M., Corsi F., Foschi D., Mazzantini E., Mazzucchelli S., Morasso C., et al. HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: outlook and recent implications in nanomedical approaches. Pharmacol. Res. 2010, 62:150-165.
30. Steinhauser I., Spankuch B., Strebhardt K., Langer K. Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. Biomaterials 2006, 27:4975-4983.
31. Hummers W.S., Offeman R.E. Preparation of graphitic oxide. J. Am. Chem. Soc. 1958, 80. 1339-1339.
32. 2 nanocrystals grown on graphene as advanced photocatalytic hybrid materials. Nano Res. 2010, 3:701-705.
33. Lee Y.R., Kim S.C., Lee H., et al. Graphite oxides as effective fire retardants of epoxy resin. Macromol. Res. 2011, 19:66-71.
34. Hu Y., Zheng X.T., Chen J.S., Zhou M.J., Li C.M., Lou X.W. Silica-based complex nanorattles as multifunctional carrier for anticancer drug. J. Mater. Chem. 2011, 21:8052-8056.
35. Zhang L.M., Lu Z.X., Zhao Q.H., Huang J., Shen H., Zhang Z.J. Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 2011, 7:460-464.
36. Watanabe T.M., Higuchi H. Stepwise movements in vesicle transport of HER2 by motor proteins in living cells. Biophys. J. 2007, 92:4109-4120.
37. Chiu Y.L., Ho Y.C., Chen Y.M., Peng S.F., Ke C.J., Chen K.J., et al. The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan. J. Control. Release 2010, 146:152-159.